Skip to content

All recalls FDA

FDADrugsRecalled Status: Ongoing

Par Health USA, LLC recalls Argatroban Injection

Class Iofficial

FDA Class I

FDA classified this recall as Class I: the most serious kind, meaning there is a reasonable chance the product could cause serious health problems or death.

Hazard
Particulate matter: particulate matter identified as cellulose, polystyrene, polyethylene teraphalate, stainless steel, or stopper material in the product solution.
Products
  • Argatroban Injection
Where it was sold

Nationwide within the United States

Nationwide

Units affected
18,991 vials
About this recall
Argatroban Injection, USP, 250 mg/2.5mL (100 mg/mL), 2.5 mL x 1 Single Dose Vial, Rx only, Manufactured for: Endo USA, Malvern,PA 19355/Argatroban Injection, 250 mg/2.5mL (100 mg/mL), 2.5 mL x 1 Single Dose Vial, Rx only, Distributed by: Par Pharmaceutical, Chestnut Ridge, NY 10977, NDC 42023-182-01.